Ozanimod a Winner in Ulcerative Colitis

(MedPage Today) -- The oral sphingosine-1-phosphate (S1P) receptor modulator ozanimod (Zeposia) was effective for induction in moderately to severely active ulcerative colitis (UC), meeting the primary endpoint in a phase III trial.
At week 10...